Nanotherapeutics in the EU: an overview on current state and future directions.
about
Fucoidans in NanomedicineA comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsNanomedicine concepts in the general medical curriculum: initiating a discussionEffects of TiO₂ and Co₃O₄ nanoparticles on circulating angiogenic cellsNanoemulsion as a carrier to improve the topical anti-inflammatory activity of stem bark extract of Rapanea ferrugineaBiocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic AdministrationNovel antigen delivery systems.Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment.Nanotherapeutics for autoimmunity becomes mainstream.Concise Review: Biomimetic Functionalization of Biomaterials to Stimulate the Endogenous Healing Process of Cartilage and Bone Tissue.Personalized Nanomedicine: A Revolution at the Nanoscale.Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development.Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation.Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies.Nanomedicine: Principles, Properties, and Regulatory IssuesHybrids of Iron-Filled Multiwall Carbon Nanotubes and Anticancer Agents as Potential Magnetic Drug Delivery Systems: In Vitro Studies against Human Melanoma, Colon Carcinoma, and Colon Adenocarcinoma
P2860
Q26739976-4B958B19-1193-446F-83AC-F5A7976973B8Q26744352-1804882C-85DC-4897-A3C4-93E69860D66DQ26775137-6F9F56B3-9DAC-4513-8A96-F9670AA3E5ABQ28390439-528E8051-E2C3-4D1D-93FE-589807BE635BQ28830541-C8875AF7-40F0-469A-933B-586D78E11DF9Q33729077-643CF73C-DD4C-40B0-8D64-9F7576E9732DQ35947894-E2A19884-5367-43CA-A8D0-ABDDE692BB92Q39030222-52CD9E03-F36A-4219-82AA-6F8A61F59D99Q42580233-89C88441-09A0-45F3-BD43-C56591090940Q47110415-A7859369-8511-4FB4-A820-FA03E6809141Q47159637-2F459EBE-1195-452B-A83F-9B5F2B3AB6C9Q47787434-1B2FC742-B563-4774-9DD9-35E840117BF7Q48309189-74B2684B-3DEF-4B2C-9ACD-A8E318258D6FQ52584444-595C944F-857F-4451-89CD-04989A99DFA6Q57168448-2EC9ECA8-9170-4D22-98A0-ECC5F8D7A40EQ59146555-137E6924-EC80-4E40-9144-42C68C98B7D5
P2860
Nanotherapeutics in the EU: an overview on current state and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanotherapeutics in the EU: an overview on current state and future directions.
@en
Nanotherapeutics in the EU: an overview on current state and future directions.
@nl
type
label
Nanotherapeutics in the EU: an overview on current state and future directions.
@en
Nanotherapeutics in the EU: an overview on current state and future directions.
@nl
prefLabel
Nanotherapeutics in the EU: an overview on current state and future directions.
@en
Nanotherapeutics in the EU: an overview on current state and future directions.
@nl
P2093
P2860
P356
P1476
Nanotherapeutics in the EU: an overview on current state and future directions.
@en
P2093
Anita Hafner
Gorana Perina Lakoš
Ivan Pepić
Jasmina Lovrić
P2860
P304
P356
10.2147/IJN.S55359
P407
P577
2014-02-19T00:00:00Z